What Albertsons Purchase of Rite Aid Means for Drug Retail
Albertsons is buying a big portion of Rite Aid to create a company worth $24 Billion. Shares of Rite Aid soared as much as 8 percent on the news. This acquisition comes as many retailers join forces to compete with Amazon, which is involved in nearly every industry from retail, to grocery, and now even healthcare. Wall Street Journal Reporter Heather Haddon and Bold Media's Business Editor David Grasso explain what this deal means for drug retail.
"Rite Aid was really put at a disadvantage right after the stuttered Walgreens deal," says Haddon. "This was really about Rite Aid helping to reposition themselves, get access to a whole new market of Albertsons customers, and in turn Albertsons gets a lot of pharmacy customers and cross-marketing opportunities."
"We are seeing a lot of disruption, and everyone is shaking in their boots," says Grasso. "It's all about survival.
Through this deal the integrated company will operate 4,900 locations, 4,350 pharmacy counters, and 320 clinics across 38 states and Washington, D.C.
Vulture contributor Fran Hoepfner talks the Wicked film's marketing campaign, why 'culture jacking' works so well and how it all paid off for the hit musical.
Brigit Zimmerman, Chief Commercial Officer at Priceline breaks down what travelers can expect this holiday season, predictions for 2025 and best ways to save.
Simon Shuster, Senior Correspondent at TIME, discusses his recent article, how the friendship between Musk and Trump may affect US spending, “DOGE” and more.
Christa Pitts, Co-Founder & Co-CEO of The Lumistella Company shares the origins of Elf on the Shelf Plus Extraordinary Noorah's Macy's Day Parade debut!
Hayley Berg, Lead Economist at Hopper breaks down her best tips for navigating holiday travel and how to score the hottest deals on Dec. 3 - Travel Deal Tuesday
MarketWatch's Hannah Erin Lang joins Cheddar to discuss how economists are viewing Trump's immigration policy and how it will affect the job market in America.
